InvestSMART

Medibank Private Limited (ASX: MPL) - Announcements

- Current share price for MPL : $5.000

ASX company news and announcements for Medibank Private Limited (MPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibank Private Limited (MPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibank Private Limited (MPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibank Private Limited (MPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13,770 Notification of cessation of securities - MPL 12 Jan 2023 8:55AM $2.850 $5.000 risen by 75.44%
$13,770 Medibank announces $207m customer cash give back 22 Dec 2022 8:59AM $2.890 $5.000 risen by 73.01%
$13,770 Cybercrime - Bannister Law OAIC representative complaint 19 Dec 2022 4:31PM $2.930 $5.000 risen by 70.65%
$13,770 FY23 Half Year - Key Dates 16 Dec 2022 9:11AM $2.970 $5.000 risen by 68.35%
$13,770 Change in substantial holding 15 Dec 2022 10:19AM $2.940 $5.000 risen by 70.07%
$13,770 Cybercrime - OAIC representative complaint 14 Dec 2022 8:55AM $2.970 $5.000 risen by 68.35%
$13,770 Notification regarding unquoted securities - MPL 13 Dec 2022 9:10AM $2.960 $5.000 risen by 68.92%
$13,770 Change of Director's Interest - David Koczkar 13 Dec 2022 9:04AM $2.960 $5.000 risen by 68.92%
$13,770 Medibank cybercrime update 1 Dec 2022 5:49PM $2.980 $5.000 risen by 67.79%
$13,770 Medibank response to APRA 28 Nov 2022 9:53AM $2.860 $5.000 risen by 74.83%
$13,770 Amended Constitution 16 Nov 2022 2:00PM $2.790 $5.000 risen by 79.21%
$13,770 Results of the 2022 Annual General Meeting 16 Nov 2022 1:56PM $2.795 $5.000 risen by 78.89%
$13,770 Chair and CEO AGM presentations and FY23 Outlook Update 16 Nov 2022 8:33AM $2.810 $5.000 risen by 77.94%
$13,770 Medibank cybercrime update 9 Nov 2022 9:53AM $2.780 $5.000 risen by 79.86%
$13,770 Medibank cybercrime update 7 Nov 2022 8:22AM $2.820 $5.000 risen by 77.30%
$13,770 Reinstatement to Official Quotation 26 Oct 2022 9:32AM $3.505 $5.000 risen by 42.65%
$13,770 Medibank cybercrime, business and FY23 outlook update 26 Oct 2022 9:32AM $3.505 $5.000 risen by 42.65%
$13,770 Medibank cybercrime update 25 Oct 2022 8:32AM $3.505 $5.000 risen by 42.65%
$13,770 Suspension from Official Quotation 21 Oct 2022 11:14AM $3.505 $5.000 risen by 42.65%
$13,770 Medibank cyber incident update response 20 Oct 2022 12:56PM $3.505 $5.000 risen by 42.65%
$13,770 Medibank cyber incident update 19 Oct 2022 4:45PM n/a $5.000 n/a
$13,770 Trading Halt 19 Oct 2022 12:48PM $3.505 $5.000 risen by 42.65%
$13,770 Pause in Trading 19 Oct 2022 11:53AM $3.505 $5.000 risen by 42.65%
$13,770 Medibank cyber incident and trading update 17 Oct 2022 9:13AM $3.520 $5.000 risen by 42.05%
$13,770 Trading Halt 13 Oct 2022 11:27AM $3.520 $5.000 risen by 42.05%

151 - 175 of 489 results

Page 7 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.